desipramine has been researched along with Carcinoma, Epidermoid in 2 studies
Desipramine: A tricyclic dibenzazepine compound that potentiates neurotransmission. Desipramine selectively blocks reuptake of norepinephrine from the neural synapse, and also appears to impair serotonin transport. This compound also possesses minor anticholinergic activity, through its affinity to muscarinic receptors.
desipramine : A dibenzoazepine consisting of 10,11-dihydro-5H-dibenzo[b,f]azepine substituted on nitrogen with a 3-(methylamino)propyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Desipramine (DMI) has been reported to induce glucocorticoid receptor-mediated signal transduction in recent studies." | 1.36 | Effects of desipramine on the cell cycle and apoptosis in Ca3/7 mouse skin squamous carcinoma cells. ( Hanausek, M; Kinjo, T; Kowalczyk, M; Kowalczyk, P; Slaga, TJ; Walaszek, Z, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kinjo, T | 2 |
| Kowalczyk, P | 2 |
| Kowalczyk, M | 2 |
| Walaszek, Z | 2 |
| Nishimaki, T | 1 |
| Slaga, TJ | 2 |
| Hanausek, M | 2 |
2 other studies available for desipramine and Carcinoma, Epidermoid
| Article | Year |
|---|---|
Desipramine inhibits the growth of a mouse skin squamous cell carcinoma cell line and affects glucocorticoid receptor-mediated transcription.
Topics: Animals; Anti-Inflammatory Agents; Antidepressive Agents, Tricyclic; Blotting, Western; Carcinoma, S | 2009 |
Effects of desipramine on the cell cycle and apoptosis in Ca3/7 mouse skin squamous carcinoma cells.
Topics: Animals; Apoptosis; Apoptosis Inducing Factor; Carcinoma, Squamous Cell; Cell Cycle; Cell Line, Tumo | 2010 |